Ronan Murphy

Dr. Ronan Murphy is a Researcher in the Rolff Group - Evolutionary Biology at the Institute of Biology, Freie Universität Berlin. His work focuses on microbial infections, antibiotic resistance mechanisms, and bacterial pathogenesis, particularly in Pseudomonas aeruginosa strains isolated from cystic fibrosis (CF) patients. He explores innovative approaches such as drug repurposing (e.g., glatiramer acetate) to combat antibiotic resistance and synergistic antibiotic combinations to enhance treatment efficacy. His research also investigates non-invasive diagnostic tools, including the use of sniffer dogs for detecting Pseudomonas aeruginosa infections in non-sputum-producing CF patients.

Dr. Murphy’s research integrates microbiology, pharmacology, and clinical studies to address critical challenges in CF-associated infections. His recent studies emphasize understanding the molecular mechanisms of antibiotic resistance, biofilm formation dynamics, and host-pathogen interactions. He collaborates on projects involving membrane-targeting antimicrobial agents and their effects on bacterial physiology.

His publications highlight advancements in antibiotic synergy testing, lipid membrane interactions, and phenotypic variations in clinical isolates. While no specific awards are listed, his contributions to cystic fibrosis microbiology and diagnostic innovation are notable. His work bridges basic science and clinical applications, aiming to improve therapeutic strategies for chronic infections.